Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiac Rhythmology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1615574

This article is part of the Research TopicAtrial Fibrillation (AF) in Heart Failure with Preserved Ejection Fraction (HFpEF)View all 5 articles

Cellular Interactions and Ion Channel Signatures in Atrial Fibrillation Remodeling: Insights from Single-Cell Analysis and Machine Learning

Provisionally accepted
Bin  HeBin He1Yan  ChengYan Cheng1Juan  WangJuan Wang1Ya  ZhanYa Zhan2*Yanqun  LiuYanqun Liu1*
  • 1The No. 1 Department of Gerontology, The Third Hospital of Mianyang, Sichuan Mental Health Center., Mianyang, China
  • 2Renal Department, The Third Hospital of Mianyang, Sichuan Mental Health Center., Mianyang, China

The final, formatted version of the article will be published soon.

Abstract Background: Atrial structural and electrical remodeling are key mechanisms in atrial fibrillation (AF). However, the cellular interactions involved in structural remodeling and ion channel markers of electrical remodeling remain incompletely understood.Methods: Single-cell RNA sequencing (scRNA-seq) was employed to investigate structural remodeling at the cellular level in AF. After quality control and clustering using Seurat, principal component analysis (PCA) identified major cell types. Monocle was used for cell trajectory analysis, and CellChat for cell–cell communication. GO, KEGG, and GSEA analyses explored functional pathways. Ion channel-related genes from microarray datasets were analyzed using LASSO and SVM algorithms to identify AF-specific biomarkers, followed by drug enrichment analysis.Results: Five fibroblast subtypes were identified: embryonic fibroblasts (EF), actively proliferating fibroblasts (APF), smooth muscle cells (SMC), endothelial cells (EC), and leukocytes (LBCs). AF samples showed increased EF, APF, and LBCs, and decreased EC proportions compared to sinus rhythm (SR) controls. Trajectory analysis indicated that EF cells may differentiate into APF and SMC. Cell–cell interaction analysis revealed enhanced LAMININ and COLLAGEN signaling in EF cells and loss of EC signals such as GRN–SORT1 and AGRN–DAG1 in AF. Reduced NPPA–NPR1 signaling from SMC to EC was also observed, suggesting their role in AF maintenance.For electrical remodeling, two ion channel genes—ANO1 and GRIK2—were identified as AF signature genes with strong diagnostic value. Drug analysis revealed that phenytoin sodium may target EF cells, while ionomycin, DIDS, citalopram, and topiramate showed strong associations with ANO1 or GRIK2, suggesting potential for drug repurposing.Conclusion: This study highlights critical changes in fibroblast subtypes, differentiation patterns, and intercellular communication contributing to AF structural remodeling. ANO1 and GRIK2 serve as key biomarkers for electrical remodeling. The identification of existing drugs targeting these components offers promising therapeutic avenues for AF treatment.

Keywords: Atrial Fibrillation, structural remodeling, electrical remodeling, Single-Cell Analysis, machine learning

Received: 21 Apr 2025; Accepted: 30 Jul 2025.

Copyright: © 2025 He, Cheng, Wang, Zhan and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Ya Zhan, Renal Department, The Third Hospital of Mianyang, Sichuan Mental Health Center., Mianyang, China
Yanqun Liu, The No. 1 Department of Gerontology, The Third Hospital of Mianyang, Sichuan Mental Health Center., Mianyang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.